Evaluation of the Impact of Chemotherapy on Body Odor in Adolescents and Young Adults in Oncology

N/ACompletedNCT04899505

Institut Curie27 enrolled

Overview

The appearance of unpleasant body odors in adolescent Young adult (aya) wille be evaluated undergoing chemotherapy

Study Type

OBSERVATIONAL

Enrollment

Conditions

Solid Tumor, Adult Solid Tumor, Childhood Chemotherapy Effect

Interventions

Evaluation on appearance of unpleasant body odorsOTHER

Percentage of patients reporting discomfort with unpleasant body odor that occurred during their treatment. This percentage will be calculated from the response to item Q1 of the patient questionnaire during the fourth course of chemotherapy in the AJA oncology department.

Eligibility

Sex: ALLMin age: 15 YearsMax age: 25 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients aged between 15 and 25 years; * New patients treated at the Curie Institute and hospitalized in the AJA oncology department; * Patient undergoing chemotherapy administered intravenously; * Solid tumors. Exclusion Criteria: * Patient undergoing oral chemotherapy; * Persons deprived of their liberty or under guardianship (including guardianship); * Inability to undergo medical monitoring of the trial for geographical, social or psychological reasons.

Locations (1)

Institut Curie

Paris, France

Outcomes

Primary Outcomes

Incidence of the development of unpleasant body odors in AYA oncology patients

Time frame: 8 months

Secondary Outcomes

Qualification of the smell and the discomfort felt

Answers to the investigation intended for patients for the appearance of the smell with different proposals like sweating, urine, breath etc. (Q2), its qualifier with different proposals like desagreable, infective, nauseating, etc…(Q3) and the discomfort observed for themselves or for those around them (Q8)

Time frame: 8 months

Quantification of the discomfort and the impact on quality of life

Answers to the investigation intended for patients to assess the intensity of the smell with a scale (0= no smell and 10 = strong smell) (Q4), its daily impact with a scale (0=no impact and 10= high impact) (Q7) and solutions that can reduce smell with different proposals like perfume, cream, essential oil (Q9)

Time frame: 8 months

Identify possible causes of the appearance of these new body odors

Answers to the investigation for patients to assess the link between smell and drug treatment with different proposals like treatment, hospital's food or hospital cleaning product (Q5 and Q6)

Time frame: 8 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.